Investing in AI-driven medtech: funding strategies and opportunities

In this keynote session, Henry Whorwood, Managing Director of Research at Beauhurst, provides a comprehensive look at the investment landscape for AI-driven MedTech ventures. He begins by introducing Beauhurst’s role in tracking the UK innovation economy, explaining how investment activity serves as a key indicator of industry health. By monitoring funding rounds across sectors, Beauhurst identifies trends that reveal which industries are thriving and where opportunities lie. Henry then delves into the transformative impact of artificial intelligence on the broader tech sector, highlighting the surge in investment for companies embracing AI. Narrowing the focus to MedTech, he examines how funding patterns reflect the sector’s resilience and growth potential. The session concludes with an analysis of AI-enabled MedTech businesses, exploring their performance and the factors influencing investor confidence. Attendees gain valuable insights into who is securing capital, where it originates, and what drives strategic investment decisions in this rapidly evolving space.